共 50 条
Influence of Sex and Hormone Status on Circulating Natriuretic Peptides
被引:142
|作者:
Lam, Carolyn S. P.
[1
,6
,7
,8
]
Cheng, Susan
[1
,2
]
Choong, Karen
[3
,4
]
Larson, Martin G.
[1
,5
]
Murabito, Joanne M.
[1
]
Newton-Cheh, Christopher
[1
,2
]
Bhasin, Shalender
[3
,4
]
McCabe, Elizabeth L.
[1
,2
]
Miller, Karen K.
[2
]
Redfield, Margaret M.
[6
]
Vasan, Ramachandran S.
[1
,7
,8
]
Coviello, Andrea D.
[1
,3
,4
,7
,8
]
Wang, Thomas J.
[1
,2
]
机构:
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[3] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA
[4] Boston Med Ctr, Boston, MA USA
[5] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[6] Mayo Clin, Rochester, MN USA
[7] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA
[8] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA
关键词:
hormones;
natriuretic peptides;
sex;
CARDIAC ENDOCRINE FUNCTION;
TANDEM MASS-SPECTROMETRY;
CORONARY HEART-DISEASE;
POSTMENOPAUSAL WOMEN;
REPLACEMENT THERAPY;
BINDING GLOBULIN;
MENSTRUAL-CYCLE;
FREE TESTOSTERONE;
FOLLICULAR PHASE;
RISK-FACTORS;
D O I:
10.1016/j.jacc.2011.03.042
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objectives The aim of this study was to assess the relationship between sex hormones and natriuretic peptide levels in community-based adults. Background Women have higher circulating natriuretic peptide concentrations than men, but the mechanisms for these sex-related differences and the impact of hormone therapy are unclear. Experimental studies suggest that androgens may suppress natriuretic peptide secretion. Methods We measured N-terminal pro-B-type natriuretic peptide (NT-proBNP), total testosterone, and sex hormone-binding globulin plasma levels in 4,056 men and women (mean age 40 +/- 9 years) from the Framingham Heart Study Third-Generation cohort. Sex/hormone status was grouped as: 1) men; 2) post-menopausal women not receiving hormone replacement therapy; 3) pre-menopausal women not receiving hormonal contraceptives; 4) post-menopausal women receiving hormone replacement therapy; and 5) pre-menopausal women receiving hormonal contraceptives. Results Circulating NT-proBNP levels were associated with sex/hormone status (overall p < 0.0001). Men had lower NT-proBNP levels than women of all menopause or hormone groups, and women receiving hormonal contraceptives had higher NT-proBNP levels than women who were not receiving hormone therapy (all p < 0.0001). These relationships remained significant after adjusting for age, body mass index, and cardiovascular risk factors. Across sex/hormone status groups, free testosterone (FT) levels decreased and sex hormone-binding globulin levels increased in tandem with increasing NT-proBNP levels. In sex-specific analyses, NT-proBNP levels decreased across increasing quartiles of FT in men (p for trend < 0.01) and women (p for trend < 0.0001). Adjustment for FT markedly attenuated the association between sex/hormone status and NT-proBNP concentrations. Conclusions These findings suggest that lower levels of circulating androgens and the potentiating effect of exogenous female hormone therapy contribute to the higher circulating NT-proBNP concentrations in women. (J Am Coll Cardiol 2011;58:618-26) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:618 / 626
页数:9
相关论文